Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 15 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 15 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 19 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 19 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

Synthetic DNA Studied for Mass Data Storage

DNA illustration

An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage

Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Global venture capital investing

Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Pharma Gains Fibrosis Technology in $1B+ Deal

Stuart Cook

Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Guidelines Proposed for Complex Clinical Trials

Chemotherapy vials

A working group published guidelines for conducting clinical trials that simultaneously test multiple cancer treatments and can change course over time. . . . → Read More: Guidelines Proposed for Complex Clinical Trials

Climate Action Cost Accounting Standard Proposed

Climate change skyline

A new paper proposes an accounting standard that would require private companies to spell out their costs of meeting net-zero greenhouse gas emissions. . . . → Read More: Climate Action Cost Accounting Standard Proposed

FDA Blocks Monthly HIV Drug Combo

T-cell infected by HIV

The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV. . . . → Read More: FDA Blocks Monthly HIV Drug Combo

Infographic – China Top Country for Science Journal Papers

Chart: scientific publications

China now leads all other countries in the sheer output of papers in peer-reviewed scientific journals, according to data from National Science Foundation. . . . → Read More: Infographic – China Top Country for Science Journal Papers

Viruses Altered to Boost Gene Therapy Delivery

Neurons

Researchers in Sweden developed a process to improve the targeting of benign viruses for delivering gene therapies to the brain. . . . → Read More: Viruses Altered to Boost Gene Therapy Delivery

Psychedelic Depression Drug Tested for Safety

Psilocybe aztecorum

Results from an early clinical trial testing an hallucinogenic drug to treat depression shows the therapy is largely safe and feasible to administer. . . . → Read More: Psychedelic Depression Drug Tested for Safety